A proteomic analysis of serum from dogs before and after a controlled weight-loss program

Domestic Animal Endocrinology

Volumn 43, Issue 4, 2012, Pages 271-277

  Tvarijonaviciute, A ^a   Gutierrez A M ^a   Miller, I ^b   Razzazi Fazeli, E ^b   Tecles, F ^a   Ceron, J J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Dog; Obesity; Proteomics; Serum; Weight loss

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; CLUSTERIN; PLASMA PROTEIN; PROTEIN PRECURSOR; RETINOL BINDING PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; FEMALE; MASS SPECTROMETRY; OBESITY; PHYSIOLOGY; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WEIGHT REDUCTION;

ALPHA 1-ANTITRYPSIN; ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CLUSTERIN; DOG DISEASES; DOGS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; MASS SPECTROMETRY; OBESITY; PROTEIN PRECURSORS; PROTEOMICS; RETINOL-BINDING PROTEINS; WEIGHT LOSS;

CANIS FAMILIARIS;

EID: 84867193866     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2012.04.004     Document Type: Article

References (44)

1. Roudebush P., Schoenherr W.D., Delaney S.J. An evidence-based review of the use of nutraceuticals and dietary supplementation for the management of obese and overweight pets. J Am Vet Med Assoc 2008, 232:1646-1653.
2. German A.J., Ryan V.H., German A.C., Wood I.S., Trayhurn P. Obesity, its associated disorders and the role of inflammatory adipokines in companion animals. Vet J 2010, 185:4-9.
3. German A.J. The growing problem of obesity in dogs and cats. J Nutr 2006, 136(7 suppl):1940S-1946S.
4. Brandacher G., Golderer G., Kienzl K., Werner E.R., Margreiter R., Weiss H.G. Potential applications of global protein expression analysis (proteomics) in morbid obesity and bariatric surgery. Obes Surg 2008, 18:905-910.
5. Cristea I.M., Gaskell S.J., Whetton A.D. Proteomics techniques and their application to hematology. Blood 2004, 103:3624-3634.
6. Dayarathna M.K., Hancock W.S., Hincapie M. A two step fractionation approach for plasma proteomics using immunodepletion of abundant proteins and multi-lectin affinity chromatography: application to the analysis of obesity, diabetes, and hypertension diseases. J Sep Sci 2008, 31:1156-1166.
7. Choi J.W., Wang X., Joo J.I., et al. Plasma proteome analysis in diet-induced obesity-prone and obesity-resistant rats. Proteomics 2010, 10:4386-4400.
8. Joo J.I., Kim D.H., Choi J.W., Yun J.W. Proteomic analysis for antiobesity potential of capsaicin on white adipose tissue in rats fed with a high fat diet. J Proteome Res 2010, 9:2977-2987.
9. Ratcliffe L., Mian S., Slater K., et al. Proteomic identification and profiling of canine lymphoma patients. Vet Comp Oncol 2009, 7:92-105.
10. Wilson C.R., Regnier F.E., Knapp D.W., Raskin R.E., Andrews D.A., Hooser S.B. Glycoproteomic profiling of serum peptides in canine lymphoma and transitional cell carcinoma. Vet Comp Oncol 2008, 6:171-181.
11. Makino T., Kinoshita J., Arakawa S., et al. Comprehensive analysis of hepatic gene and protein expression profiles on phenobarbital- or clofibrate-induced hepatic hypertrophy in dogs. J Toxicol Sci 2009, 34:647-661.
12. Britti D., Gaspari M., Massimini G., Casalinuovo F., Morittu V.M., Cuda G. Proteomic analysis in canine leishmaniasis. Vet Res Commun 2010, 34(suppl 1):S91-S96.
13. Tvarijonaviciute A., Tecles F., Martínez-Subiela S., Ceron J.J. Effects of experimental weight loss in selected inflammatory analytes in dog serum. Vet J 2012 Mar 29, [Epub ahead of print].
14. Yamka R.M., Friesen K.G., Frantz N.Z. Identification of canine markers related to obesity and the effects of weight loss on the markers of interest. Int J Appl Res Vet Med 2006, 4:282-292.
15. Blanchard G., Nguyen P., Gayet C., Leriche I., Siliart B., Paragon B.M. Rapid weight loss and a high-protein low-energy diet allows the recovery of ideal body composition and insulin sensitivity in obese dogs. J Nutr 2004, 134(8 suppl):2148-2150.
16. Son H.R., d'Avignon D.A., Laflamme D.P. Comparison of dual-energy x-ray absorptiometry and measurement of total body water content by deuterium oxide dilution for estimating body composition in dogs. Am J Vet Res 1998, 59:529-532.
17. Westermeier R., Naven T., Höpker H.R. Proteomics in Practice-A Guide to Successful Experimental Design 2008, Wiley-VCH, Weinheim, Germany. 2nd ed.
18. Miller I., Gemeiner M. Two-dimensional electrophoresis of cat sera: protein identification by cross reacting antibodies against human serum proteins. Electrophoresis 1992, 13:450-453.
19. Miller I., Wait R., Sipos W., Gemeiner M. A proteomic reference map for pig serum proteins as a prerequisite for diagnostic applications. Res Vet Sci 2009, 86:362-367.
20. Diez M., Michaux C., Jeusette I., Baldwin P., Istasse L., Biourge V. Evolution of blood parameters during weight loss in experimental obese Beagle dogs. J Physiol Nutr (Berl) 2004, 88:166-171.
21. German A.J., Hervera M., Hunter L., et al. Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest Anim Endocrinol 2009, 37:214-226.
22. Fahiminiya S., Reynaud K., Labas V., Batard S., Chastant-Maillard S., Gérard N. Steroid hormones content and proteomic analysis of canine follicular fluid during the preovulatory period. Reprod Biol Endocrinol 2010, 8:132.
23. Kirby G.M., Mackay A., Grant A., et al. Concentration of lipocalin region of collagen XXVII alpha 1 in the serum of dogs with hemangiosarcoma. J Vet Intern Med 2011, 25:497-503.
24. Selvaraju S., Rassi Z.E. Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis-an update covering the period 2008-2011. Electrophoresis 2012, 33:74-88.
25. Jenne D.E., Lowin B., Peitsch M.C., Böttcher A., Schmitz G., Tschopp J. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J Biol Chem 1991, 266:11030-11036.
26. Oberbach A., Blüher M., Wirth H., et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 2011, 10:4769-4788.
27. Pervaiz S., Brew K. Homology and structure-function correlations between alpha 1-acid glycoprotein and serum retinol-binding protein and its relatives. FASEB J 1987, 1:209-214.
28. Cowan S.W., Newcomer M.E., Jones T.A. Crystallographic refinement of human serum retinol binding protein at 2A resolution. Proteins 1990, 8:44-61.
29. Yang Q., Graham T.E., Mody N., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362.
30. Graham T.E., Yang Q., Blüher M., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006, 354:2552-2563.
31. Stefan N., Hennige A.M., Staiger H., et al. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 2007, 30:1173-1178.
32. Haider D.G., Schindler K., Prager G., et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007, 92:1168-1171.
33. Lee J.W., Im J.A., Lee H.R., Shim J.Y., Youn B.S., Lee D.C. Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women. Obes Silver Spring 2007, 15:2225-2232.
34. Travis J., Shieh B.H., Potempa J. The functional role of acute phase plasma proteinase inhibitors. Tokai J Exp Clin Med 1988, 13:313-320.
35. Janciauskiene S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta 2001, 1535:221-235.
36. Engström G., Hedblad B., Stavenow L., Lind P., Janzon L., Lindgärde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003, 52:2097-2101.
37. Engström G., Stavenow L., Hedblad B., et al. Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk. Arterioscler Thromb Vasc Biol 2003, 23:2247-2251.
38. Engström G., Stavenow L., Hedblad B., et al. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 2003, 52:442-447.
39. Mashiba S., Wada Y., Takeya M., et al. In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL. Arterioscler Thromb Vasc Biol 2001, 21:1801-1808.
40. Fischer C.L., Gill C., Forrester M.G., Nakamura R. Quantitation of acute-phase proteins postoperatively. Value in detection and monitoring of complications. Am J Clin Pathol 1976, 66:840-846.
41. Conner J.G., Eckersall P.D., Ferguson J., Douglas T.A. Acute phase response in the dog following surgical trauma. Res Vet Sci 1988, 45:107-110.
42. Chapman M.J. Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol 1986, 128:70-143.
43. Arai T., Yamashita S., Hirano K., et al. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 1994, 14:1129-1136.
44. Jeusette I., Daminet S., Nguyen P., et al. Effect of ovariectomy and ad libitum feeding on body composition, thyroid status, ghrelin and leptin plasma concentrations in female dogs. J Anim Physiol Anim Nutr (Berl) 2006, 90:12-18.